Brevan Howard Capital Management’s Henry Schein HSIC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-61,381
Closed -$4.52M – 2281
2026
Q1
$4.52M Buy
+61,381
New +$4.74M 0.04% 268
2025
Q4
– Sell
-43,224
Closed -$2.87M – 2020
2025
Q3
$2.87M Sell
43,224
-12,453
-22% -$862K 0.01% 423
2025
Q2
$4.07M Buy
+55,677
New +$3.83M 0.02% 451
2024
Q3
– Sell
-6,508
Closed -$417K – 1271
2024
Q2
$417K Buy
6,508
+3,092
+91% +$218K ﹤0.01% 671
2024
Q1
$258K Sell
3,416
-7,279
-68% -$546K ﹤0.01% 714
2023
Q4
$810K Buy
+10,695
New +$748K 0.01% 300

Other funds holding HSIC

Brevan Howard Capital Management's HSIC Position: Q2 2026 in Review

Brevan Howard Capital Management sold out of Henry Schein (HSIC) in Q2 2026, closing a stake of 61,381 shares — an estimated $4.52M sold.

Brevan Howard Capital Management first reported a position in HSIC in Q4 2023 and held it in 6 quarters. The position peaked at $4.52M in Q1 2026. 566 funds tracked by Wall St. Rank hold HSIC as of Q2 2026.

  • Brevan Howard Capital Management reported no remaining Henry Schein position as of Q2 2026 after selling out during the quarter.
  • Brevan Howard Capital Management sold 61,381 Henry Schein shares in Q2 2026, an estimated $4.52M.
  • Brevan Howard Capital Management first reported a position in Henry Schein in Q4 2023 and held it in 6 quarters.
  • Brevan Howard Capital Management's Henry Schein position peaked at $4.52M in Q1 2026.
  • 566 funds tracked by Wall St. Rank held Henry Schein as of Q2 2026.

Based on Brevan Howard Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.